Dr. Davit Mrelashvili is a board certified neurologist, a published clinical researcher, entrepreneur and business executive who practices neurology at the University of South Carolina and serves as advisor and key opinion leader on product development for multiple large pharmaceutical organizations..
Davit completed his medical internship at Emory University and his neurology residency at the Vanderbilt University School of Medicine. Since joining the faculty in 2008, Davit continues to hold an academic appointment in the neurology department of the University Of South Carolina School Of Medicine.
In addition to an active clinical practice and specialization in Multiple Sclerosis (MS), he has contributed to clinical research involving both MS and stroke patients. This includes participation in a number of local research activities and designation as site principle investigator and co-investigator in nationwide multi center clinical trials sponsored by both the NIH and private companies.He teaches medical students and educates neurology residents at the bedside to enhance their understanding of real-world clinical challenges. The entrepreneur in Davit is constantly motivated to identify and address current patient and physician needs on a larger scale with the ultimate goal of improving care and outcomes. He is inspired by the work at Juno Biomedical and has made the decision to join as the company’s second C-level position in 2016.
Also a business executive, Davit graduated from the professional MBA track at Darla Moore School of Business in 2011 and received executive coaching through the Singularity University Executive program in 2015. Davit applies his executive leadership skills to his local community by serving as vice-chair at Palmetto-Health Rich land Department of Neurology as well as several other executive level engagements nationwide and internationally. Additionally, Davit is a Key Opinion Leader for a number of pharmaceutical giants, including Biogen, Teva and Pfizer,and sits on the advisory board for other large MedTech companies including Novartis, Genentech and Bayer.
In parallel, Davit has been involved in telemedicine -- an innovative and exponential way of practicing medicine. Licensed to practice in 18 states and holding active staff privileges in over 130 hospitals, Davit delivers time-sensitive acute stroke care via telemedicine to many underserved ERs across the country. This ‘on demand’ service involves beaming in the two-way video robot and doing real-time consultation for patients with urgent and critical needs.
Davit is passionate about the potential that today’s and the near future’s technology holds for medicine and strives to put those technologies to work to cure human diseases.